Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AKR1B1 | P15121 | 10/20 | 0.54 |
| ▸ | PTGDR2 | Q9Y5Y4 | 4/20 | 0.46 |
| ▸ | SLC22A12 | Q96S37 | 5/20 | 0.44 |
| ▸ | KMO | O15229 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5317956 | 0.90 | AKR1B1 (0.56) | AKR1B1PTGDR2SLC22A12 | |
| SCHEMBL5318259 | 0.89 | KMO (0.46) | AKR1B1PTGDR2SLC22A12KMO | |
| SCHEMBL5317839 | 0.89 | AKR1B1 (0.55) | AKR1B1PTGDR2SLC22A12 | |
| SCHEMBL5316058 | 0.88 | KMO (0.44) | AKR1B1PTGDR2SLC22A12KMO | |
| SCHEMBL4097771 | 0.86 | CYP1A2 (0.54) | AKR1B1PTGDR2SLC22A12KMO | |
| SCHEMBL5270492 | 0.86 | AKR1B1 (0.39) | AKR1B1PTGDR2SLC22A12KMO | |
| SCHEMBL5318197 | 0.85 | PTGDR2 (0.49) | AKR1B1PTGDR2SLC22A12KMO | |
| SCHEMBL5317400 | 0.85 | SLC22A12 (0.52) | AKR1B1PTGDR2SLC22A12KMO | |
| SCHEMBL5318544 | 0.84 | AKR1B1 (0.38) | AKR1B1PTGDR2SLC22A12KMO | |
| SCHEMBL5317649 | 0.83 | AKR1B1 (0.38) | AKR1B1PTGDR2SLC22A12KMO |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2502624-A1 | Lonidamine analogues and their use in male contraception and cancer treatment | THE UNIVERSITY OF KANSAS (US) | 2012-09-26 | — | — | EP | claimed |
| EP-1786424-A2 | LONIDAMINE ANALOGUES AND THEIR USE IN MALE CONTRACEPTION AND CANCER TREATMENT | The University of Kansas (US) | 2007-05-23 | — | — | EP | claimed |
| WO-2006023704-A2 | LONIDAMINE ANALOGUES AND THEIR USE IN MALE CONTRACEPTION AND CANCER TREATMENT | UNIVERSITY OF KANSAS (US) | 2006-03-02 | — | — | WO | claimed |
| EP-2502624-A1 | Lonidamine analogues and their use in male contraception and cancer treatment | THE UNIVERSITY OF KANSAS (US) | 2012-09-26 | — | — | EP | disclosed |